This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eoin O'Connor: Innovator in Medicinal Chemistry
Introduction
Eoin O'Connor is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for therapeutic use. His work focuses on creating effective inhibitors that can lead to advancements in medical treatments.
Latest Patents
Eoin O'Connor holds a patent for Alkynyl-(heteroaryl)-carboxamide HCN1 inhibitors. The present invention provides compounds of formula I wherein R, R', or R'' are as described herein, as well as pharmaceutically acceptable salts thereof. Furthermore, the invention is concerned with the manufacture of these compounds, pharmaceutical compositions comprising them, and their use as medicaments. He has 1 patent to his name.
Career Highlights
Eoin O'Connor is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves extensive research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for health challenges.
Collaborations
Eoin has collaborated with several esteemed colleagues, including Bjoern Bartels and Jean-Yves Wach. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Eoin O'Connor's contributions to medicinal chemistry and his innovative patent work exemplify his commitment to advancing healthcare solutions. His ongoing efforts at Hoffmann-La Roche Inc. continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile